Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Bukwang Pharmaceutical Co., Ltd. (003000)
Market Closed
15 Jun, 06:30
KRX SM
All
(1)
KR
(1)
KRX SM
Primary
₩
4,775.
00
+300
+6.7039%
₩
416.86B
Market Cap
-
P/E Ratio
125%
Div Yield
1.5M
Volume
0
Eps
₩
4,475
Previous Close
Watching
Watch
Add Transaction
Day Range
4,395
4,795
Year Range
3,200
9,890
Want to track
003000
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
Historical Data
Bukwang Pharmaceutical Co., Ltd. (003000) Statistics
Valuation metrics
Market Cap
416.86B
Enterprise value
407.76B
Trailing P/E (ttm)
31.27
Forward P/E
-
PEG ratio
0.02
Price/Sales (ttm)
2.2
Price/Book (mrq)
1.31
Enterprise Value/Revenue
2.03
Enterprise Value/EBITDA
22.3
Overview
Shares outstanding
98.66M
Float
70.64M
Shares short
-
% Held by insiders
0.31%
% Held by institutions
0.02%
Average volume (10 days)
433.15K
Average volume (90 days)
2.38M
Price summary
52-Week low
3,200
52-Week high
9,890
Beta
0.23
50-Day moving average
5,475.62
200-Day moving average
5,265.56
Dividends and splits
Forward annual dividend rate
125
Forward annual dividend yield
0.0243%
Trailing annual dividend rate
125
Trailing annual dividend yield
0.0279%
5-Year annual dividend yield
0.82%
Payout ratio
0.35
Dividend Date
20 Nov 2025
Ex-Dividend Date
4 Nov 2025
Last split factor
1:1
Last split Date
29 Dec 2020
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.07%
Operating margin
0.06%
Operational effectiveness
Return on assets
0.03%
Return on equity
0.04%
Income Statement
Revenue (ttm)
200.71B
Revenue per share (ttm)
2,061.59
Quarterly revenue growth (yoy)
0.35%
Gross profit (ttm)
91.53B
EBITDA
11.85B
Net income to common (ttm)
12.56B
Diluted EPS (ttm)
143.12
Quarterly earnings growth (yoy)
1.53%
Balance Sheet
Total cash (mrq)
216.21B
Total cash per share (mrq)
2,151.37
Total debt (mrq)
80.34B
Total Debt/Equity (mrq)
0.24
Current ratio (mrq)
2.55%
Book value per share (mrq)
3,428.86
Cash Flow
Cash flow statement
21.46B
Levered free cash flow (LFCF)
-9.89B